- Home
- CAC vs LXRX Comparison
CAC vs LXRX Comparison
Compare CAC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- LXRX
- Stock Information
- Founded
- CAC 1875
- LXRX 1995
- Country
- CAC United States
- LXRX United States
- Employees
- CAC N/A
- LXRX N/A
- Industry
- CAC Major Banks
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- LXRX Health Care
- Exchange
- CAC Nasdaq
- LXRX Nasdaq
- Market Cap
- CAC 680.5M
- LXRX 552.4M
- IPO Year
- CAC 1997
- LXRX 2000
- Fundamental
- Price
- CAC $38.83
- LXRX $1.25
- Analyst Decision
- CAC Buy
- LXRX Buy
- Analyst Count
- CAC 3
- LXRX 5
- Target Price
- CAC $47.33
- LXRX $3.23
- AVG Volume (30 Days)
- CAC 76.5K
- LXRX 2.0M
- Earning Date
- CAC 10-28-2025
- LXRX 11-06-2025
- Dividend Yield
- CAC 4.33%
- LXRX N/A
- EPS Growth
- CAC 9.13
- LXRX N/A
- EPS
- CAC 3.49
- LXRX N/A
- Revenue
- CAC $215,172,000.00
- LXRX $70,864,000.00
- Revenue This Year
- CAC $44.50
- LXRX $66.55
- Revenue Next Year
- CAC $7.03
- LXRX N/A
- P/E Ratio
- CAC $11.12
- LXRX N/A
- Revenue Growth
- CAC 27.50
- LXRX 1255.21
- 52 Week Low
- CAC $34.53
- LXRX $0.28
- 52 Week High
- CAC $50.07
- LXRX $1.66
- Technical
- Relative Strength Index (RSI)
- CAC 52.74
- LXRX 40.69
- Support Level
- CAC $37.78
- LXRX $1.31
- Resistance Level
- CAC $39.35
- LXRX $1.53
- Average True Range (ATR)
- CAC 0.92
- LXRX 0.08
- MACD
- CAC 0.22
- LXRX -0.02
- Stochastic Oscillator
- CAC 59.62
- LXRX 18.57
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.